Elizabeth S. Rich, MD, PhD

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

1. Clinical and safety profile of high-dose interleukin-2 treatment in elderly patients with metastatic melanoma and renal cell carcinoma.
   Clark JM, Kelley B, Titze J, Fung H, Maciejewski J, Nathan S, Rich E, Basu S, Kaufman HL.
   Oncology. 2013
   2013
   84(2):123-6. doi: 10.1159/000342764. Epub 2012 Dec 7.
   
2. Loss of CD26 protease activity in recipient mice during hematopoietic stem cell transplantation results in improved transplant efficiency.
   Yoo E, Paganessi LA, Alikhan WA, Paganessi EA, Hughes F, Fung HC, Rich E, Seong CM, Christopherson 2nd KW.
   Transfusion. 2012
   2012 Aug 6. doi: 10.1111/j.1537-2995.2012.03826.x. [Epub ahead of print]
   
3. Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26(-)(/-) mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis
   Paganessi LA, Walker AL, Tan LL, Holmes I, Rich E, Fung HC, Christopherson KW 2nd
   Exp Hematol
   2011 Mar
   39(3):384-90
   
4. Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions.
   Liu H, Rich ES, Godley L, Odenike O, Joseph L, Marino S, Kline J, Nguyen V, Cunningham J, Larson RA, Del Cerro P, Schroeder L, Pape L, Stock W, Wickrema A, Artz AS, van Besien K.
   Blood.
   2011 Dec 8
   118(24):6438-45
   
5. Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant.
   Godley LA, Njiaju UO, Green M, Weiner H, Lin S, Odenike O, Rich ES, Artz A, Van Besien K, Daugherty CK, Zhang Y, Le Beau MM, Stock W, Larson RA.
   Leuk Lymphoma.
   2010 Jun
   51(6):995-1006.
   
6. Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26(-/-) mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis
   Paganessi LA, Walker AL, Tan LL, Holmes I, Rich E, Fung HC, Christopherson KW 2nd
   Exp Hematol
   2010 Dec 16
   
7. Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.
   Artz AS, Wickrema A, Dinner S, Godley LA, Kocherginsky M, Odenike O, Rich ES, Stock W, Ulaszek J, Larson RA, van Besien K.
   Biol Blood Marrow Transplant.
   2008 Nov
   14(11):1209-16.
   
8. Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
   Arai S, Meagher R, Swearingen M, Myint H, Rich E, Martinson J, Klingemann H
   Cytotherapy
   2008
   10(6):625-32